Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Tdap (tetanus, diphtheria, pertussis) is recommended for all adolescents and adults, and during every pregnancy. As one of the most commonly administered vaccines, it generates significant VAERS reports.
The following symptoms are most frequently reported after vaccination:
Tdap is recommended during weeks 27-36 of every pregnancy to protect newborns from whooping cough (pertussis). This means a large portion of Tdap VAERS reports come from pregnant women, which may include pregnancy complications that arecoincidental rather than vaccine-caused.
Large-scale studies have found Tdap during pregnancy to be safe, with no increased risk of major birth defects, preterm birth, or small-for-gestational-age births.
Common:
Less common:
Rare: